CN101869688A - Chinese medicinal compound preparation for treating uterine myoma - Google Patents
Chinese medicinal compound preparation for treating uterine myoma Download PDFInfo
- Publication number
- CN101869688A CN101869688A CN201010203446A CN201010203446A CN101869688A CN 101869688 A CN101869688 A CN 101869688A CN 201010203446 A CN201010203446 A CN 201010203446A CN 201010203446 A CN201010203446 A CN 201010203446A CN 101869688 A CN101869688 A CN 101869688A
- Authority
- CN
- China
- Prior art keywords
- parts
- leaf
- radix
- preparation
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 33
- 206010046798 Uterine leiomyoma Diseases 0.000 title claims abstract description 23
- 150000001875 compounds Chemical class 0.000 title claims abstract description 12
- 238000011282 treatment Methods 0.000 claims abstract description 16
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 8
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 8
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 8
- 210000000582 semen Anatomy 0.000 claims description 16
- 241000208340 Araliaceae Species 0.000 claims description 14
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 14
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 14
- 235000008434 ginseng Nutrition 0.000 claims description 14
- 238000009472 formulation Methods 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 11
- 241000283956 Manis Species 0.000 claims description 7
- 241001250596 Pleione Species 0.000 claims description 7
- 235000013399 edible fruits Nutrition 0.000 claims description 7
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 11
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- 241000220431 Adenanthera Species 0.000 abstract 1
- 235000011470 Adenanthera pavonina Nutrition 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000512259 Ascophyllum nodosum Species 0.000 abstract 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract 1
- 240000009138 Curcuma zedoaria Species 0.000 abstract 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 abstract 1
- 241000123589 Dipsacus Species 0.000 abstract 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 abstract 1
- 241000766380 Iphigenia Species 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 244000059675 Lindernia crustacea Species 0.000 abstract 1
- 244000215554 Nepeta hederacea Species 0.000 abstract 1
- 235000011755 Nepeta hederacea Nutrition 0.000 abstract 1
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 241000283966 Pholidota <mammal> Species 0.000 abstract 1
- 241001103621 Psychotria Species 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 241001530126 Scrophularia Species 0.000 abstract 1
- 241000329195 Sparganium erectum Species 0.000 abstract 1
- 244000107975 Strychnos nux-vomica Species 0.000 abstract 1
- 244000178320 Vaccaria pyramidata Species 0.000 abstract 1
- 235000010587 Vaccaria pyramidata Nutrition 0.000 abstract 1
- 235000007212 Verbena X moechina Moldenke Nutrition 0.000 abstract 1
- 240000001519 Verbena officinalis Species 0.000 abstract 1
- 235000001594 Verbena polystachya Kunth Nutrition 0.000 abstract 1
- 235000007200 Verbena x perriana Moldenke Nutrition 0.000 abstract 1
- 235000002270 Verbena x stuprosa Moldenke Nutrition 0.000 abstract 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 abstract 1
- 229940107131 ginseng root Drugs 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 230000007721 medicinal effect Effects 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 235000019509 white turmeric Nutrition 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 31
- 210000004369 blood Anatomy 0.000 description 31
- 239000003814 drug Substances 0.000 description 27
- 229920003266 Leaf® Polymers 0.000 description 24
- 208000002193 Pain Diseases 0.000 description 17
- 230000001737 promoting effect Effects 0.000 description 16
- 230000017531 blood circulation Effects 0.000 description 12
- 201000010099 disease Diseases 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 210000004291 uterus Anatomy 0.000 description 12
- 208000029312 Muscular tumor Diseases 0.000 description 11
- 201000000736 Amenorrhea Diseases 0.000 description 9
- 206010001928 Amenorrhoea Diseases 0.000 description 9
- 231100000540 amenorrhea Toxicity 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- 206010030113 Oedema Diseases 0.000 description 8
- 210000001015 abdomen Anatomy 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 206010012335 Dependence Diseases 0.000 description 7
- 208000005171 Dysmenorrhea Diseases 0.000 description 7
- 206010013935 Dysmenorrhoea Diseases 0.000 description 7
- 230000002146 bilateral effect Effects 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 7
- 208000006820 Arthralgia Diseases 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 230000002175 menstrual effect Effects 0.000 description 6
- 244000052769 pathogen Species 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 206010027514 Metrorrhagia Diseases 0.000 description 5
- 230000003187 abdominal effect Effects 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 230000005906 menstruation Effects 0.000 description 5
- 230000027758 ovulation cycle Effects 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 208000019255 Menstrual disease Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 208000025747 Rheumatic disease Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 201000007227 lymph node tuberculosis Diseases 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 230000000552 rheumatic effect Effects 0.000 description 4
- 238000005096 rolling process Methods 0.000 description 4
- 230000004936 stimulating effect Effects 0.000 description 4
- 208000010392 Bone Fractures Diseases 0.000 description 3
- 206010017076 Fracture Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 241001523579 Ostrea Species 0.000 description 3
- 230000005856 abnormality Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 229940100691 oral capsule Drugs 0.000 description 3
- 230000003389 potentiating effect Effects 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 238000010025 steaming Methods 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010018498 Goitre Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 206010041349 Somnolence Diseases 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 206010000059 abdominal discomfort Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000035508 accumulation Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 201000003872 goiter Diseases 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 208000013403 hyperactivity Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 230000003119 painkilling effect Effects 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000001215 vagina Anatomy 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 206010068402 Cervix inflammation Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000004929 Facial Paralysis Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010019705 Hepatic pain Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 206010053156 Musculoskeletal discomfort Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000006374 Uterine Cervicitis Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 208000036826 VIIth nerve paralysis Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000037006 agalactosis Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 206010008323 cervicitis Diseases 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000009519 contusion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000002592 echocardiography Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000005986 heart dysfunction Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 201000010260 leiomyoma Diseases 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 206010028417 myasthenia gravis Diseases 0.000 description 1
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 229940023488 pill Drugs 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000004999 sex organ Anatomy 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000027849 smooth muscle hyperplasia Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a Chinese medicinal compound preparation for treating uterine myoma. The Chinese medicinal compound preparation consists of a preparation for oral administration and a preparation for external application, wherein the preparation for oral administration comprises the following components in part by weight: 5 to 15 parts of Chinese angelica, 5 to 15 parts of szechuan lovage rhizome, 5 to 15 parts of rehmanniae vaporata, 5 to 15 parts of white paeony root, 6 to 18 parts of salivia chinensis, 6 to 18 parts of fibrous ginseng root, 5 to 15 parts of pangolin scales (concoction), 5 to 15 parts of common burreed rhizome, 10 to 20 parts of zedoary, 25 to 35 parts of calcined oyster shell, 5 to 15 parts of scrophularia root, 6 to 18 parts of root of red-rooted salvia, 6 to 18 parts of dipsacus root, 5 to 15 parts of poria, 5 to 15 parts of panax notoginseng, 5 to 15 parts of kelp, 15 to 25 parts of european verbena, 5 to 15 parts of cowherb seed, 5 to 15 parts of Indian iphigenia bulb and 5 to 15 parts of brittle falsepimpernel herb; and the preparation for external application comprises the following components in part by weight: 4 to 16 parts of nux vomica, 5 to 15 parts of pnus massoniana leaf, 5 to 17 parts of siam psychotria leaf, 4 to 15 parts of bead tree leaf, 3 to 16 parts of whiteflower leadword root leaf, 5 to 16 parts of common jasminorange leaf and twig and 4 to 17 parts of glechoma hederacea L. The Chinese medicinal compound preparation for treating the uterine myoma has the advantages of short course of treatment, definite and obvious curative effect and no side effect by applying the pharmacology and medicinal effect of the oral administration and external application of traditional Chinese medicines.
Description
Technical field
The present invention relates to a kind of compound Chinese medicinal preparation for the treatment of hysteromyoma.
Background technology
Hysteromyoma is a modal benign tumor in the female sex organ.Its definite diagnosis forms by uterine smooth muscle hyperplasia, wherein contains a spot of fibrous connective tissue, but be not to be the element of muscular tumor, so should be " leiomyoma of uterus " common name " hysteromyoma ".The clinical manifestation of hysteromyoma often has or not secondary degeneration and complication etc. with muscular tumor growth site, size, the speed of growth and is different, many clinically patients are asymptomatic, only idol is found when pelvioscopy, and it is metrorrhagia, abdominal mass, pain, adjacent organs pressure symptom, leucorrhoea grow in quantity, infertile, secondary anemia and heart dysfunction etc. that 20%-50% muscular tumor common sympton is arranged approximately.The difficult statistics of the incidence rate of hysteromyoma, a lot of patients are because of asymptomatic or because of the less clinical difficult discovery of muscular tumor.Hysteromyoma is more common in 30-50 year women, has 20% women that hysteromyoma is arranged approximately, and women's sickness rate in 40-50 year is the highest.Hysteromyoma belongs to the traditional Chinese medical science " stone addiction " category.The traditional Chinese medical science thinks that stopping in the addiction blood is the pathogenesis key of primary disease, so method of treatment is abided by " hard masses should be resolved gradually; diseases with invaded pathogens should be treated by expelling; disease caused by accumulations of pathogen should be treated with therapy of dispersion; disease with retention of pathogen in the body should be treated by elimination therapy " that " element ask the most pure virginity will discuss greatly " proposes more, the method for " can make removing mass, can make the heavily fortified point of bursting ", invigorating blood circulation of employing is tired, and the removing mass dispersing tumor is major-minorly to invigorate blood circulation or rush down down by the addiction or the methods such as mending combination that disappears so that temperature is logical.Be divided into clinically: stop strongly fragrant and heat-transformation in the addiction blood; Cold coagulation blood addiction; Stagnation of QI blood is tired; Accumulation of phlegm in the hypochondrium is tied mutually; The dialectical treatments of disease type such as deficiency of vital energy blood addiction obtain better curative effect.At present, western medical treatment mainly adopts operative treatment, brings very heavy mental burden and financial burden for patient and household, and side effect is in various degree arranged.
The medicine of existing this disease of treatment has:
1, the plain smg of basic hot ball in the hormone, the hot ball of oral or propanoic acid is from ketone 251ng intramuscular injection, and a multiple month total amount should not surpass 300mg, and this medicine is selected in clinical observation for use, and side effect is arranged.As: patient's self-induction addiction expands, and the part weight in patients excessively increases.
2, Ramulus Cinnamomi obtains tea pill thing and forms: Ramulus Cinnamomi, obtain tea, Radix Paeoniae Rubra, Cortex Moutan, Semen Persicae, clinical observation: type of hyperactivity of fire caused by deficiency of YIN, menstrual period, menorrhagia person should not take.
3, palace tumor capsule for eliminating medicine is formed: Rhizoma Curcumae, rhizoma sparganic, Radix Et Rhizoma Rhei, the Rhizoma Atractylodis Macrocephalae, astragalus, clinical observation, curative effect reaches 2-3.
4, BAIXIAO DAN: clinically be applicable to the treatment hysteromyoma, but curative effect reaches 2-3.
Summary of the invention
The objective of the invention is in order to overcome weak point of the prior art, a kind of pharmacology and drug effect of using oral medicinal herb, external application be provided, reach short treating period, determined curative effect obviously, the compound Chinese medicinal preparation of the treatment hysteromyoma that has no side effect.
In order to achieve the above object, the present invention adopts following scheme:
A kind of compound Chinese medicinal preparation for the treatment of hysteromyoma, wherein this compound Chinese medicinal preparation is made of oral preparations and externally applied formulation, and its oral preparations is composed of the following components by weight:
Radix Angelicae Sinensis 5-15 Rhizoma Chuanxiong 5-15
Radix Rehmanniae Preparata 5-15 Radix Paeoniae Alba 5-15
Cortex Moutan 6-18 Leptoradix Ginseng 6-18
Squama Manis (big gun) 5-15 rhizoma sparganic 5-15
Rhizoma Curcumae 10-20 Calcined Concha Ostreae 25-35
The Ginseng 5-15 of unit Radix Salviae Miltiorrhizae 6-18
Radix Dipsaci 6-18 Poria 5-15
Radix Notoginseng 5-15 Thallus Laminariae (Thallus Eckloniae) 5-15
Herba Verbenae 15-25 Semen Vaccariae 5-15
Pseudobulbus Cremastrae Seu Pleiones 5-15 Herba Leonuri 5-15;
Described externally applied formulation is composed of the following components by weight:
Semen Strychni 4-16 horse hair Folium Pini 5-15
Herba Psychotriae Siamicae leaf 5-17 bitter fruit leaf 4-15
Radix Plumbaginis Zeylanicae leaf 3-16 leaf of Folium Et Cacumen Murrayae 5-16
Herba Glechomae 4-17.
In the oral preparations of the present invention:
Radix Angelicae Sinensis: sweet, hot, temperature.Return liver, the heart, spleen channel.Enrich blood and invigorate blood circulation, menstruction regulating and pain relieving, loosening bowel to relieve constipation.Be used for blood deficiency and yellow complexion, dizzy cardiopalmus, menoxenia, amenorrhea dysmenorrhea, asthenia cold abdominalgia, dryness of the intestine constipation, rheumatic arthralgia, injury from falling down, ulcer sores.The Radix Angelicae Sinensis promoting blood circulation to restore menstrual flow.Be used for the amenorrhea dysmenorrhea, rheumatic arthralgia, injury from falling down.
Rhizoma Chuanxiong: suffering, temperature, lively atmosphere circulation of qi promoting, dispel the wind, rise the mediation of loosing; Blood-activating and qi-promoting, wind-expelling pain-stopping.Be used to pacify nerve, positive wind syndrome of head headache, lump in the abdomen stomachache, the twinge of the breast side of body, tumbling and swelling, headache, rheumatic arthralgia.
Radix Rehmanniae Preparata: sweet, tepor, have the YIN nourishing of enriching blood effect and be used for blood deficiency and yellow complexion, dizzy, palpitation and insomnia, menoxenia, diseases such as metrorrhagia.Can be used for deficiency of kidney yin hectic fever hectic fever due to YIN-deficiency, night sweat, pass out semen, quench one's thirst etc.
The Radix Paeoniae Alba: bitter, calculate, be slightly cold, the suppressing the hyperactive liver pain relieving, nourish blood and cloudy;
Cortex Moutan: hot, bitter, be slightly cold, blood circulation promoting and blood stasis dispelling, control amenorrhea; Clearing away heat and cooling blood is used for maculae caused by violent heat pathogen, tells, is defeated in battle, has blood in stool, the hectic fever due to YIN-deficiency consumptive fever, and the amenorrhea dysmenorrhea, carbuncle sore tumefacting virus falls and pounces on the pain of injury.
Leptoradix Ginseng: sweet, little hardship, tepor, strongly invigorating primordial QI; QI invigorating is promoted the production of body fluid, and quenches the thirst.Control cough and spit blood, thirsty, the insufficiency of stomach vomiting.
Squama Manis: salty, little hardship, the stimulating milk secretion of stimulating the menstrual flow, dispel the wind; Parasite killing, promoting the circulation of blood, the dissipating blood stasis of assaulting fortified position is controlled numbness and is stimulated the menstrual flow
Rhizoma sparganic: bitter, flat, removing blood stasis promoting the circulation of QI to relieve pain, removing food stagnancy eliminating stagnation; Be used for the lump in the abdomen mass in the abdomen, blood stasis amenorrhea, food stagnation distending pain
Rhizoma Curcumae: hardship, suffering, temperature, removing blood stasis promoting the circulation of QI to relieve pain, removing food stagnancy eliminating stagnation;
Calcined Concha Ostreae: salty, the stimulating milk secretion that is slightly cold, stimulates the menstrual flow, dispel the wind; Yin fluid astringing, YANG hyperactivity suppressing, hidroschesis, arresting seminal emission reduces phlegm, softening the hard mass.Dizzy, spontaneous perspiration, night sweat, seminal emission, stranguria with turbid discharge, metrorrhagia, leukorrhagia, scrofula, goiter
The Ginseng of unit: bitter in the mouth is slightly cold, main pathogenic cold in abdomen heat localization, and the surplus disease of woman's galactopoiesis, the kidney invigorating gas, it is bright to make us order;
Radix Salviae Miltiorrhizae: be slightly cold.GUIXIN, Liver Channel.Promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, removing heat from blood eliminating carbuncle, the relieving restlessness that clears away heart-fire, nourishing blood to tranquillize the mind.Cure mainly menoxenia, the amenorrhea dysmenorrhea, lump in the abdomen, breast ventral spine pain, pyretic arthralgia pain, skin infection swells and ache, dysphoria and insomnia; Hepatosplenomegaly, angina pectoris.
Radix Dipsaci: bitter, little suffering, temperature, end metrorrhagia, antiabortive, control aching pain in waist and back, the foot and knee being feeble, vaginal bleeding during pregnancy, metrorrhagia, leukorrhagia, seminal emission, traumatic injury, incised wound, anal fistula, the carbuncle skin ulcer is swollen.
Poria: sweet, light, equal, return lung, stomach, kidney channel, anticancer, the diuretic dissipating fluid-retention of relieving internal heat, spleen invigorating mind calming.Promoting diuresis to eliminate damp pathogen, spleen invigorating is reduced phlegm, mind tranquilizing and the heart calming;
Radix Notoginseng: sweet, little hardship, tepor, blood stasis dispelling, reducing swelling and alleviating pain; Have good hemostasia effect, significant hemopoietic function;
Thallus Laminariae (Thallus Eckloniae): salty, cold, expectorant, softening the hard mass, eliminating stagnation; Eliminating phlegm and softening indurated mass, inducing diuresis to remove edema.Be used for the goiter scrofula, diseases such as edema.
Herba Verbenae: bitter, cold, promoting blood circulation to remove blood stasis, diuresis promoting; Preventing the attack (or recurrence) of malaria, detoxifcation, inducing diuresis to remove edema.Be used for lump in the abdomen, amenorrhea dysmenorrhea, malaria, sore throat, carbuncle, edema, pyretic stranguria.
Semen Vaccariae: bitter, parallel blood stimulates the menstrual flow, the stimulating milk secretion detumescence; Be used for agalactia, amenorrhea, dysmenorrhea, acute mastitis swells and ache
Pseudobulbus Cremastrae Seu Pleiones: be slightly cold, little hardship, promoting blood circulation to remove blood stasis; Heat-clearing and toxic substances removing, dissipating phlegm and resolving masses.Be used for the carbuncle furunculosis, scrofula sucutaneous nodule, tuberculous lymphadenitis, snake bite and insect sting
Herba Leonuri: hot, little hardship, flat, promoting blood circulation to restore menstrual flow, inducing diuresis to remove edema; Be used for menoxenia, dysmenorrhea, amenorrhea, lochiorrhea, edema oliguria; Acute nephritis edema.
In the externally applied formulation of the present invention:
Semen Strychni: temperature, blood circulation promoting and blood stasis dispelling, promoting the circulation of QI to relieve pain; Control the throat arthralgia pain, swollen ulcer drug, migratory arthralgia pain, fracture, facial paralysis, myasthenia gravis
Horse hair Folium Pini: bitter, temperature, invigorate blood circulation;
Herba Psychotriae Siamicae leaf: bitter, cold, heat-clearing and toxic substances removing; Wind-expelling pain-stopping; The dissipating blood stasis hemostasis.Main flu; Cough; The intestinal inflammation; Dysentery; Rheumatic ostalgia; Traumatic injury; Fracture
Bitter fruit leaf: bitter, cold, poisonous
The Radix Plumbaginis Zeylanicae leaf: the dehumidifying of pungent, poisonous, the gas of dispelling; Anticancer, dispersing swelling and dissipating binds, stasis-dispelling and pain-killing relieve internal heat.
Leaf of Folium Et Cacumen Murrayae: suffering, hardship, tepor, gas perfume (or spice); Use traumatic injury, bones and muscles pain, the tendon breaking fracture, sprain and contusion are sprained, congestive edema
Herba Glechomae: sweet, little hardship, be slightly cold, gas perfume (or spice), promoting blood circulation to remove obstruction in the collateral, invigorating spleen to remove dampness, inducing diuresis for treating stranguria syndrome, removing damp and stopping pain
In sum, beneficial effect of the present invention:
Chinese medicine preparation of the present invention is by the pharmacology and the drug effect of utilization oral medicinal herb, external application, in the hope of reach short treating period, determined curative effect obviously, the therapeutic effect that has no side effect.
The specific embodiment
Below in conjunction with the specific embodiment the present invention is described further:
The present invention treats the compound Chinese medicinal preparation of hysteromyoma, is made of oral preparations and externally applied formulation, and wherein oral preparations is composed of the following components by weight:
Radix Angelicae Sinensis 5-15 Rhizoma Chuanxiong 5-15
Radix Rehmanniae Preparata 5-15 Radix Paeoniae Alba 5-15
Cortex Moutan 6-18 Leptoradix Ginseng 6-18
Squama Manis (big gun) 5-15 rhizoma sparganic 5-15
Rhizoma Curcumae 10-20 Calcined Concha Ostreae 25-35
The Ginseng 5-15 of unit Radix Salviae Miltiorrhizae 6-18
Radix Dipsaci 6-18 Poria 5-15
Radix Notoginseng 5-15 Thallus Laminariae (Thallus Eckloniae) 5-15
Herba Verbenae 15-25 Semen Vaccariae 5-15
Pseudobulbus Cremastrae Seu Pleiones 5-15 Herba Leonuri 5-15;
Described externally applied formulation is composed of the following components by weight:
Semen Strychni 4-16 horse hair Folium Pini 5-15
Herba Psychotriae Siamicae leaf 5-17 bitter fruit leaf 4-15
Radix Plumbaginis Zeylanicae leaf 3-16 leaf of Folium Et Cacumen Murrayae 5-16
Herba Glechomae 4-17.
The embodiment 1 of oral preparations of the present invention, composed of the following components by weight:
Radix Angelicae Sinensis 5 Rhizoma Chuanxiongs 5
Radix Rehmanniae Preparata 5 Radix Paeoniae Albas 5
Cortex Moutan 6 Leptoradix Ginseng 6
Squama Manis (big gun) 5 rhizoma sparganic 5
Rhizoma Curcumae 10 Calcined Concha Ostreaes 25
The Ginseng of unit 5 Radix Salviae Miltiorrhizaes 6
Radix Dipsaci 6 Poria 5
Radix Notoginseng 5 Thallus Laminariae (Thallus Eckloniae)s 5
Herba Verbenae 15 Semen Vaccariae 5
Pseudobulbus Cremastrae Seu Pleiones 5 Herba Leonuris 5.
After above-mentioned all medicine preparations, pulverized 200 mesh sieves, fine powder is encapsulated both must oral capsule preparation of the present invention.Consumption: at every turn obey 6～10 grams, every day 2～3 times.
The embodiment 1 of externally applied formulation of the present invention, composed of the following components by weight:
Semen Strychni 4 horse hair Folium Pinis 5
Herba Psychotriae Siamicae leaf 5 bitter fruit leafs 4
Radix Plumbaginis Zeylanicae leaf 3 leaf of Folium Et Cacumen Murrayae 5
Herba Glechomae 4.
Above-mentioned all medicines by behind the proportioning consumption proportion, are ground into the coarse powder shape, coarse powder is packed in the 100 gram pouches, external application abdominal part after the last stove steaming, multiple day is once.
The embodiment 2 of oral preparations of the present invention, composed of the following components by weight:
Radix Angelicae Sinensis 15 Rhizoma Chuanxiongs 15
Radix Rehmanniae Preparata 15 Radix Paeoniae Albas 15
Cortex Moutan 18 Leptoradix Ginseng 18
Squama Manis (big gun) 15 rhizoma sparganic 15
Rhizoma Curcumae 20 Calcined Concha Ostreaes 35
The Ginseng of unit 15 Radix Salviae Miltiorrhizaes 18
Radix Dipsaci 18 Poria 15
Radix Notoginseng 15 Thallus Laminariae (Thallus Eckloniae)s 15
Herba Verbenae 25 Semen Vaccariae 15
Pseudobulbus Cremastrae Seu Pleiones 15 Herba Leonuris 15.
After above-mentioned all medicine preparations, pulverized 200 mesh sieves, fine powder is encapsulated both must oral capsule preparation of the present invention.Consumption: at every turn obey 6～10 grams, every day 2～3 times.
The embodiment 2 of externally applied formulation of the present invention, composed of the following components by weight:
Semen Strychni 16 horse hair Folium Pinis 15
Herba Psychotriae Siamicae leaf 17 bitter fruit leafs 15
Radix Plumbaginis Zeylanicae leaf 16 leaf of Folium Et Cacumen Murrayae 16
Herba Glechomae 17.
Above-mentioned all medicines by behind the proportioning consumption proportion, are ground into the coarse powder shape, coarse powder is packed in the 100 gram pouches, external application abdominal part after the last stove steaming, multiple day is once.
The embodiment 3 of oral preparations of the present invention, composed of the following components by weight:
Radix Angelicae Sinensis 10 Rhizoma Chuanxiongs 8
Radix Rehmanniae Preparata 9 Radix Paeoniae Albas 7
Cortex Moutan 8 Leptoradix Ginseng 14
Squama Manis (big gun) 12 rhizoma sparganic 11
Rhizoma Curcumae 16 Calcined Concha Ostreaes 30
The Ginseng of unit 14 Radix Salviae Miltiorrhizaes 7
Radix Dipsaci 13 Poria 12
Radix Notoginseng 6 Thallus Laminariae (Thallus Eckloniae)s 10
Herba Verbenae 12 Semen Vaccariae 8
Pseudobulbus Cremastrae Seu Pleiones 9 Herba Leonuris 10.
After above-mentioned all medicine preparations, pulverized 200 mesh sieves, fine powder is encapsulated both must oral capsule preparation of the present invention.Consumption: at every turn obey 6～10 grams, every day 2～3 times.
The embodiment 3 of externally applied formulation of the present invention, composed of the following components by weight:
Semen Strychni 8 horse hair Folium Pinis 10
Herba Psychotriae Siamicae leaf 11 bitter fruit leafs 12
Radix Plumbaginis Zeylanicae leaf 6 leaf of Folium Et Cacumen Murrayae 15
Herba Glechomae 14.
Above-mentioned all medicines by behind the proportioning consumption proportion, are ground into the coarse powder shape, coarse powder is packed in the 100 gram pouches, external application abdominal part after the last stove steaming, multiple day is once.
Below in conjunction with some concrete model cases for oral administration and externally applied formulation effect of product of the present invention is made further proof:
Model case:
Hysteromyoma medical record one
Lee, the woman 39 years old, went to a doctor in JIUYUE in 2007 on the 10th.The main suit: menstruation continues 5 days, and amount is many, (every day with toilet paper 1 bag) band clot, color is scarlet, August 27 light purplish tongue, white and thin fur, thready and rolling pulse.Now toward history: over 4 years, the last week is carried in menstruation again, measures a lot of.
B ultrasonic shows: uterus 68 * 5 * 5, the visible 1.6x1.5 echo in rear wall place subtract slightly group, to projection in utero.Prompting: hysteromyoma
In examine: pudendum, vagina (-), cervical hypertrophy, light, anteversion of uterus, increase as pregnant 10 week size, matter is hard, bilateral adnexa (-)
Dialectical: (disease is silly for qi depression to blood stasis
Method of treatment: promoting QI to circulate and dispersing the agglomeration of the pathogens, removing blood stasis with potent drugs eliminating mass
Side's medicine: medicine muscular tumor internal diabetes ball of the present invention for oral administration, three times on the one, one time 6 gram, external application medicine flesh of the present invention is warded off inner dissipation, and an order once subtracts greatly through treating three menstrual cycle (hemorrhage phase removing stasis to stop bleeding) symptom.B ultrasonic shows: 44x 4 * 3.2 bilateral adnexaes in uterus are slightly unusual, follow up a case by regular visits to recurrence half a year.
JIUYUE was examined in 13 days two, and vagina does not have bloodstain, insufficiency of blood, light red tongue purple, thready and rolling pulse.Medicine of the present invention for oral administration: muscular tumor internal diabetes ball, external application medicine of the present invention: the muscular tumor external application is loose.Continuously with 3 menstrual cycle.B ultrasonic shows: the uterus increases, and dwindles 2/3, continues three menstrual cycle of treatment.
December 28 days: all diseases of patient disappear.B ultrasonic shows: 53 * 40 * 3.1 bilateral adnexa no abnormality seens, and follow up a case by regular visits to and do not recur half a year.
Hysteromyoma medical record two
Lee, the woman 38 years old, goes to a doctor on January 9th, 2008.
The main suit: menstruation shifts to an earlier date sometimes, and nearly March, amount in the period increased, and clot is arranged, and continued the .8 month 10 more than 7 days at every turn, through the sleepy fatigue in back, and stomach discomfort, waist ship-acid is expanded, and accompanies vulva pruritus, the near first quarter moon pharyngalgia celostomia of catching a cold, dark tongue quality, white and thin fur, thready and rolling pulse.
B ultrasonic: sub-official 8.3 * 6.1 * 4.2 in utero echo owes all, and visible 13 * 1.0 echoes in rear wall place subtract dark group, and behind the uterus visible 6.1x4.9 no echo area, clear border.Prompting: hysteromyoma
In examine: vulvovaginal (-) cervicitis, body of uterus anteposition increase as pregnant 7 week size, matter is hard, and is movable good, bilateral adnexa (-)
Plating is picked up: mycete (-) infusorian (-)
Dialectical: stagnation of liver-QI with deficiency of the spleen (lump in the abdomen)
Method of treatment: soothing liver and strengthening spleen, removing blood stasis with potent drugs eliminating mass.
Prescription: 1, medicine muscular tumor internal diabetes ball of the present invention for oral administration, 3 times on the 1st, 1 time 6 gram.
2, the external application of external application medicine muscular tumor of the present invention is loose.Once-a-day.Method: with cloth bag medicament, steamed 20 minutes, put abdominal part minute, once-a-day.
According to last method three menstrual cycle of taking medicine, all diseases disappear.
B ultrasonic shows: 50x 4.1 * 3.0 bilateral adnexa no abnormality seens, and follow up a case by regular visits to and do not recur half a year.
Hysteromyoma medical record three Zhangs, the woman 40 years old, goes to a doctor on January 10th, 2008.
The main suit: menstruation shifts to an earlier date sometimes, and nearly March, amount in the period increased, and clot is arranged, and continued more than 7 days at every turn.August 12, through after sleepy fatigue, stomach discomfort, soreness of waist and legs, dark tongue quality, white and thin fur, thready and rolling pulse.
B ultrasonic: uterus 7.5 * 5.0 * 4.0 in utero echo owes all to examine hysteromyoma clearly.
In examine: vulvovaginal () Uterine Cervix inflammation, the body of uterus anteposition increases as pregnant 7w size, matter is hard, and is movable good, the bilateral adnexa.
Dialectical: stagnation of liver-QI with deficiency of the spleen (lump in the abdomen)
The rule of treatment: soothing liver and strengthening spleen, removing blood stasis with potent drugs eliminating mass.
Prescription: 1, medicine muscular tumor internal diabetes ball of the present invention for oral administration, 3 times on the 1st, 1 time 6 gram.
2, the external application of external application medicine muscular tumor of the present invention is loose.Method: with cloth bag medicament, steamed 20 minutes, put the abdominal part rattan 40 minutes, once-a-day.According to last method three menstrual cycle of taking medicine, all diseases disappear.
B ultrasonic shows: 52 * 4.0 * 2.8 bilateral adnexa no abnormality seens, and follow up a case by regular visits to and do not recur half a year.There is abundant, detailed embodiment to support the content that claims and description are put down in writing.
Claims (1)
1. a compound Chinese medicinal preparation for the treatment of hysteromyoma is characterized in that this compound Chinese medicinal preparation is made of oral preparations and externally applied formulation, and its oral preparations is composed of the following components by weight:
Radix Angelicae Sinensis 5-15 Rhizoma Chuanxiong 5-15
Radix Rehmanniae Preparata 5-15 Radix Paeoniae Alba 5-15
Cortex Moutan 6-18 Leptoradix Ginseng 6-18
Squama Manis (big gun) 5-15 rhizoma sparganic 5-15
Rhizoma Curcumae 10-20 Calcined Concha Ostreae 25-35
The Ginseng 5-15 of unit Radix Salviae Miltiorrhizae 6-18
Radix Dipsaci 6-18 Poria 5-15
Radix Notoginseng 5-15 Thallus Laminariae (Thallus Eckloniae) 5-15
Herba Verbenae 15-25 Semen Vaccariae 5-15
Pseudobulbus Cremastrae Seu Pleiones 5-15 Herba Leonuri 5-15;
Described externally applied formulation is composed of the following components by weight:
Semen Strychni 4-16 horse hair Folium Pini 5-15
Herba Psychotriae Siamicae leaf 5-17 bitter fruit leaf 4-15
Radix Plumbaginis Zeylanicae leaf 3-16 leaf of Folium Et Cacumen Murrayae 5-16
Herba Glechomae 4-17.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102034466A CN101869688B (en) | 2010-06-11 | 2010-06-11 | Chinese medicinal compound preparation for treating uterine myoma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102034466A CN101869688B (en) | 2010-06-11 | 2010-06-11 | Chinese medicinal compound preparation for treating uterine myoma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101869688A true CN101869688A (en) | 2010-10-27 |
| CN101869688B CN101869688B (en) | 2011-11-30 |
Family
ID=42994894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010102034466A Expired - Fee Related CN101869688B (en) | 2010-06-11 | 2010-06-11 | Chinese medicinal compound preparation for treating uterine myoma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101869688B (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102429959A (en) * | 2011-12-21 | 2012-05-02 | 王俪晓 | Medicament for treating gynecopathy and venereal diseases |
| CN102552619A (en) * | 2012-01-16 | 2012-07-11 | 张铁军 | Medicine for treating tumor and preparation method thereof |
| CN103251745A (en) * | 2013-05-20 | 2013-08-21 | 广州国宇医药科技有限公司 | Traditional Chinese medicine composition for inhibiting hysteromyoma |
| CN105056126A (en) * | 2015-08-14 | 2015-11-18 | 殷永洲 | Traditional Chinese medicine composition for treating hysteromyoma |
| CN106237253A (en) * | 2016-09-08 | 2016-12-21 | 四川聚豪生物科技有限公司 | A kind of Chinese medicine composition treating hysteromyoma and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1686407A (en) * | 2005-04-19 | 2005-10-26 | 王福斗 | Gynecopathy convalescence powder |
| CN1903224A (en) * | 2006-08-01 | 2007-01-31 | 董草原 | Method for comprehensive processing and preparing of traditional Chinese medicine |
-
2010
- 2010-06-11 CN CN2010102034466A patent/CN101869688B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1686407A (en) * | 2005-04-19 | 2005-10-26 | 王福斗 | Gynecopathy convalescence powder |
| CN1903224A (en) * | 2006-08-01 | 2007-01-31 | 董草原 | Method for comprehensive processing and preparing of traditional Chinese medicine |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102429959A (en) * | 2011-12-21 | 2012-05-02 | 王俪晓 | Medicament for treating gynecopathy and venereal diseases |
| CN102429959B (en) * | 2011-12-21 | 2013-08-28 | 王俪晓 | Medicament for treating gynecopathy and venereal diseases |
| CN102552619A (en) * | 2012-01-16 | 2012-07-11 | 张铁军 | Medicine for treating tumor and preparation method thereof |
| CN102552619B (en) * | 2012-01-16 | 2013-12-18 | 张铁军 | Medicine for treating tumor and preparation method thereof |
| CN103251745A (en) * | 2013-05-20 | 2013-08-21 | 广州国宇医药科技有限公司 | Traditional Chinese medicine composition for inhibiting hysteromyoma |
| CN105056126A (en) * | 2015-08-14 | 2015-11-18 | 殷永洲 | Traditional Chinese medicine composition for treating hysteromyoma |
| CN106237253A (en) * | 2016-09-08 | 2016-12-21 | 四川聚豪生物科技有限公司 | A kind of Chinese medicine composition treating hysteromyoma and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101869688B (en) | 2011-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1302801C (en) | Compound traditional Chinese medicine formulation for curing hysteromyoma | |
| CN101869688B (en) | Chinese medicinal compound preparation for treating uterine myoma | |
| CN104208554A (en) | Traditional Chinese medicine mainly for treating multiple female diseases | |
| CN104043022A (en) | Traditional Chinese medicine composition for treating gynecologic inflammation | |
| CN104173565B (en) | A kind of Chinese medicine composition treating menoxenia | |
| CN102198242B (en) | Traditional Chinese medicine composition for treating hysteromyoma | |
| CN103007093A (en) | Medicine for treating gynecological inflammation and preparation method thereof | |
| CN102416146B (en) | Chinese medicinal composition for treating amenorrhea | |
| CN103212020A (en) | Traditional Chinese medicine composition for treating functional dyspepsia | |
| CN103157062A (en) | Medicine composition curing gynaecological mass diseases such as fibroids and preparation method and application thereof | |
| CN102670925B (en) | Medicament for treating irregular menstruation and preparation method thereof | |
| CN105749167A (en) | Traditional Chinese medicine composition for treating amenorrhea | |
| CN102038889B (en) | Traditional Chinese medicament for treating rheumatic heart disease | |
| CN105663408A (en) | Decoction medicine for treating abnormal menstruation and insufficient menstrual blood volume as well as preparation method thereof | |
| CN104306872A (en) | Traditional Chinese medicine for treating uterine fibroid | |
| CN104069305A (en) | Traditional Chinese medicine composition for treating chronic pelvic inflammation and preparation method thereof | |
| CN104173981A (en) | Medical decoction for treating uterine fibroids and hypertrophy of uterus and preparation method thereof | |
| CN104288581A (en) | Traditional Chinese medicine for treating threatened abortion | |
| CN102895564A (en) | Chinese medicine for treating tubal nowhere and preparation method thereof | |
| CN105853782A (en) | Traditional Chinese medicinal composition for treating uterine prolapsed | |
| CN104840757A (en) | Traditional Chinese medicine preparation for alleviating dysmenorrheal and preparation method | |
| CN105194577A (en) | Medicament for treating hyperplasia of mammary glands | |
| CN104666819A (en) | Chinese medicine bath with effects of clearing liver-heat and regulating menstruation | |
| CN104800824A (en) | Soft capsule for treating postpartum lochiorrhea and preparation method of soft capsule | |
| CN104069387A (en) | Traditional Chinese medicine composition for treating chronic annexitis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: ZHONGSHAN HYGENE MEDICINE BIOLOGICAL ENGINEERING C Free format text: FORMER OWNER: ZHONGSHAN HAIJI CHINESE MEDICINE DEVELOPMENT CO., LTD. Effective date: 20111017 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20111017 Address after: 528400 No. 16, biological Valley Road, Zhongshan Torch Development Zone, Guangdong, Zhongshan Applicant after: Zhongshan Haiji Medicine Biological Engineering Co Ltd Address before: 528400 No. 16, biological Valley Road, Torch Development Zone, Guangdong, Zhongshan Applicant before: Zhongshan Haiji Chinese Medicine Development Co., Ltd. |
|
| C56 | Change in the name or address of the patentee |
Owner name: ZHONGSHAN HYGENE BIOPHARM CO., LTD. Free format text: FORMER NAME: ZHONGSHAN HYGENE MEDICINE BIOLOGICAL ENGINEERING CO., LTD. |
|
| CP01 | Change in the name or title of a patent holder |
Address after: 528400 No. 16, biological Valley Road, Zhongshan Torch Development Zone, Guangdong, Zhongshan Patentee after: Zhongshan Hygene Biopharm Co., Ltd. Address before: 528400 No. 16, biological Valley Road, Zhongshan Torch Development Zone, Guangdong, Zhongshan Patentee before: Zhongshan Haiji Medicine Biological Engineering Co Ltd |
|
| CP03 | Change of name, title or address |
Address after: 528400 No. 16, biological Valley Road, Torch Development Zone, Guangdong, Zhongshan Patentee after: Zhongshan Haiji Weiming Biological Medicine Co Ltd Address before: 528400 No. 16, biological Valley Road, Zhongshan Torch Development Zone, Guangdong, Zhongshan Patentee before: Zhongshan Hygene Biopharm Co., Ltd. |
|
| CP03 | Change of name, title or address | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20111130 Termination date: 20200611 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |